STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[6-K] Meihua International Medical Technologies Co., Ltd. Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K
Rhea-AI Filing Summary

Meihua International Medical Technologies Co., Ltd. (MHUA) furnished a Current Report on Form 6-K dated September 18, 2025 that attaches unaudited condensed consolidated financial statements covering the six months ended June 30, 2025 and June 30, 2024, plus a Management's Discussion and Analysis of Financial Condition and Results of Operations. The filing includes Inline XBRL exhibits (101.*) and a Cover Page Interactive Data File. The report indicates these exhibits are furnished under the Securities Act and Exchange Act and incorporated by reference into specified Form F-3 and Form F-1 registration statements to the extent not superseded by later filings. The document is signed by the Chief Executive Officer, Leyi Lee.

Positive
  • Unaudited condensed consolidated financial statements for the six months ended June 30, 2025 and June 30, 2024 were furnished
  • Management's Discussion and Analysis was furnished, providing narrative context to interim results
  • Inline XBRL exhibits (101.*) and an interactive cover page were included, enabling machine‑readable analysis
Negative
  • None.

Insights

TL;DR: Six‑month unaudited financials and MD&A were furnished, enabling updated investor review.

The furnished unaudited condensed consolidated financial statements for the six months ended June 30, 2025 and June 30, 2024 provide a new interim snapshot of operating results and financial position for that period. The inclusion of a Management's Discussion and Analysis gives narrative context to those numbers, which is essential for interpreting trends and management's view of performance.

These exhibits are delivered in Inline XBRL format (101.*), which supports machine‑readable analysis and comparability. Watch for the specific line‑item changes within the June 30, 2025 statements and MD&A—those will determine material impacts on liquidity, revenue, expenses, or contingencies in the near term.

TL;DR: Filing appears procedural and correctly furnishes financial exhibits and XBRL data for investor access.

The report furnishes exhibits intended to be incorporated by reference into the listed Form F‑3 and Form F‑1 registration statements "to the extent not superseded" by later filings, which is standard practice for maintaining up‑to‑date prospectus information. The signature by the Chief Executive Officer satisfies the furnishing requirement.

Investors and analysts should consult the actual Inline XBRL exhibits to extract specific numeric changes and confirm whether any subsequent filings supersede these exhibits within the registration statements.

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE

SECURITIES EXCHANGE ACT OF 1934

 

For the month of September 2025

 

Commission File Number 001- 41291

 

Meihua International Medical Technologies Co., Ltd. 

(Translation of registrant’s name into English)

 

88 Tongda Road, Touqiao Town

Guangling District, Yangzhou, 225000

People’s Republic of China

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 

Form 20-F          Form 40-F

 

 

 

 

 

Explanatory Note

 

Meihua International Medical Technologies Co., Ltd. (the “Company”) is furnishing its unaudited financial statements for the six months ended June 30, 2025 and incorporating such financial statements into the Company’s registration statements referenced below. The financial statements and notes are attached as Exhibit 99.1 to this report. Management’s Discussion and Analysis of Financial Condition and Results of Operations for the six months ended June 30, 2025 is attached as Exhibit 99.2 to this report.

 

This Form 6-K is hereby incorporated by reference into the registration statement on Form F-3 (File Number: 333-274194), as amended, and Form F-1 (File Number: 333-276882), as amended, of the Company, and into the prospectus outstanding under the foregoing registration statement, to the extent not superseded by documents or reports subsequently filed or furnished by the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.

 

1

 

 

EXHIBIT INDEX

 

Exhibit No.   Description
99.1   Unaudited Condensed Consolidated Financial Statements for the Six Months Ended June 30, 2025 and 2024
99.2   Management’s Discussion and Analysis of Financial Condition and Results of Operations
101.INS   Inline XBRL Instance Document
101.SCH   Inline XBRL Taxonomy Extension Schema Document
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.  

 

  Meihua International Medical Technologies Co., Ltd.
   
Dated: September 18, 2025   
  By: /s/ Leyi Lee
  Name: Leyi Lee
  Title: Chief Executive Officer
(Principal Executive Officer)

 

 

3

 

001-41291

FAQ

What did Meihua (MHUA) file in the Form 6‑K dated September 18, 2025?

The company furnished unaudited condensed consolidated financial statements for the six months ended June 30, 2025 and June 30, 2024, plus a Management's Discussion and Analysis and Inline XBRL exhibits.

Does the 6‑K include machine‑readable financial data for MHUA?

Yes. The filing includes Inline XBRL exhibits (101.INS, 101.SCH, 101.CAL, 101.DEF, 101.LAB, 101.PRE) and a Cover Page Interactive Data File.

Will the furnished exhibits update MHUA's registration statements?

The exhibits are furnished to be incorporated by reference into specified Form F‑3 and Form F‑1 registration statements "to the extent not superseded" by later filings, per the filing language.

Who signed the 6‑K for Meihua (MHUA)?

The report is signed by Leyi Lee, Chief Executive Officer (Principal Executive Officer).

Are the financial statements audited?

No. The filing states the condensed consolidated financial statements are unaudited for the six‑month periods.
Meihua International Medical Technologies Co., Ltd.

NASDAQ:MHUA

MHUA Rankings

MHUA Latest News

MHUA Latest SEC Filings

MHUA Stock Data

12.71M
39.97M
49.95%
0.52%
0.05%
Medical Instruments & Supplies
Healthcare
Link
China
Yangzhou